腔腸素h/腔腸素400a/天然腔腸素

1. INJ Inject-A-Lume h-Coelenterazine 注射型h-腔腸素

【簡介】注射型h-腔腸素，純度高（99%），針對活體研究進(jìn)行優(yōu)化。苯甲基腔腸素（h-CTZ)封裝于小體積的無菌注射瓶中。每個(gè)試劑盒提供兩瓶500 µg的注射型h-CTZ和一瓶無菌注射型稀釋液。僅供動(dòng)物使用。啟維益成提供腔腸素。啟維益成公司代理nanolight全線產(chǎn)品。

【使用案例】

Rd R W, Oner S S, Lanier S M, et al. Direct Coupling of a Seven-Transmembrane-Span Receptor to a Gαi G-Protein Regulatory Motif Complex.[J]. Molecular Pharmacology, 2015, 88.

Ciruela F, Fernández-Dueñas V. GPCR oligomerization analysis by means of BRET and dFRAP.[J]. Methods in Molecular Biology, 2015, 1272(1272):133-41.

Schena A, Griss R, Johnsson K. Modulating protein activity using tethered ligands with mutually exclusive binding sites.[J]. Nature Communications, 2015, 6.

 

2. Coelenterazine-SOL in vivo 水溶性腔腸素（活體研究）

【貨號(hào)】cat#3031

【產(chǎn)品簡介】天然腔腸素被制定為水溶性的（天然腔腸素+無毒水溶性添加劑），可安全應(yīng)用于海腎螢光素酶的活體成像。腔腸素經(jīng)常溶于丙二醇（PG）結(jié)合其他醇類的混合溶劑中，應(yīng)用于活體成像研究。短時(shí)間內(nèi)靜脈注射大劑量PG是有毒性的，包括高滲性、增加陰離子代謝性酸中毒（由于乳酸性酸中毒）、急性腎損傷以及血性癥候群。使用水溶性腔腸素可避免上述問題，它被制定為等滲壓以及易于被腎臟分泌的，從而避免重復(fù)性的活體注射。水溶性的腔腸素最高注射濃度可達(dá)500 µg/100 µl，在機(jī)體內(nèi)能夠達(dá)到一個(gè)相當(dāng)高腔腸素水平，帶來強(qiáng)烈的海腎熒光素信號(hào)。

【使用案例】

Yao M, Lu X, Lei Y, et al. Conditional Inducible Triple-Transgenic Mouse Model for Rapid Real-Time Detection of HCV NS3/4A Protease Activity.[J]. Plos One, 2016, 11(3).

 

3. Coelenterazin h 腔腸素h

【貨號(hào)】cat#301 、CAS#50909-86-9

【簡介】腔腸素h，是一種天然腔腸素的脫氧衍生物。當(dāng)使用原水母發(fā)光蛋白時(shí)，腔腸素h的原始光輸出量高于腔腸素的兩倍；當(dāng)使用水母螢光素酶時(shí)，腔腸素h的原始光輸出量減少卻有更長時(shí)間的持續(xù)性活躍。啟維益成提供腔腸素。啟維益成公司代理nanolight全線產(chǎn)品。

【使用案例】

Charles R, Namkung Y, Cotton M, et al. βarrestin-Mediated Angiotensin II Signaling Controls the Activation of ARF6 and Endocytosis in Migration of Vascular Smooth Muscle Cells.[J]. Journal of Biological Chemistry, 2015.

Lahaie N, Kralikova M, Pr E L, et al. Post-endocytotic deubiquitination and degradation of the metabotropic γ-aminobutyric acid receptor by the ubiquitin specific protease 14.[J]. Journal of Biological Chemistry, 2016.

Beata J, Yuanyuan C, Tivadar O, et al. Disruption of Rhodopsin Dimerization with Synthetic Peptides Targeting an Interaction Interface.[J]. Journal of Biological Chemistry, 2015, 290(42):25728-44.

Gimenez L E, Baameur F, Vayttaden S J, et al. Salmeterol Efficacy and Bias in the Activation and Kinase-Mediated Desensitization of β2-Adrenergic Receptors[J]. Molecular pharmacology, 2015, 87(6): 954-964.

Hu J, Stern M, Gimenez L E, et al. A G Protein-Biased Designer G Protein-Coupled Receptor Useful for Studying the Physiological Relevance of Gq/11-Dependent Signaling Pathways.[J]. Journal of Biological Chemistry, 2016.

Giner X C, Cotnoir-White D, Mader S, et al. Selective ligand activity at Nur/retinoid X receptor complexes revealed by dimer-specific bioluminescence resonance energy transfer-based sensors.[J]. Faseb Journal, 2015, 29(10).

Lim J H, Park G C, Lee S M, et al. Surface-Tunable Bioluminescence Resonance Energy Transfer via Geometry-Controlled ZnO Nanorod Coordination[J]. Small, 2015, 11(28):3469-3475.

Robertson D N, Sleno R, Nagi K, et al. Design and construction of conformational biosensors to monitor ion channel activation: A prototype FlAsH/BRET-approach to Kir3 channels[J]. Environmental Modelling & Software, 2015, 8(9):A21.

Nakajima K I, Gimenez L E D, Gurevich V V, et al. Design and Analysis of an Arrestin-Biased DREADD[J]. Neuromethods, 2015, 108:29-48.

Lee J, Ghil S. Regulator of G protein signaling 8 inhibits protease-activated receptor 1/Gi/o signaling by forming a distinct G protein-dependent complex in live cells.[J]. Cellular Signalling, 2016, 28(5):391-400.

Zhao P, Lieu T, Barlow N, et al. Neutrophil elastase activates PAR2 and TRPV4 to cause inflammation and pain.[J]. Journal of Biological Chemistry, 2015.

Guixà-González R, Javanainen M, Gómez-Soler M, et al. Membrane omega-3 fatty acids modulate the oligomerisation kinetics of adenosine A2Aand dopamine D2receptors[J]. Scientific Reports, 2015, 6.

Chen Y, Hong T. High-throughput screening assays to identify small molecules preventing photoreceptor degeneration caused by the rhodopsin P23H mutation.[M]// Rhodopsin. Springer New York, 2015:369-390.

 

4. Coelenterazine native 天然腔腸素

【貨號(hào)】cat#303、CAS#55779-48-1

【簡介】腔腸素游離堿，純度>95%。它是自然界最豐富的腔腸素，是海腎螢光素酶的首選底物。啟維益成提供腔腸素。啟維益成公司代理nanolight全線產(chǎn)品。

【使用案例】

Franchi F, Peterson K M, Paulmurugan R, et al. Noninvasive Monitoring of the Mitochondrial Function in Mesenchymal Stromal Cells[J]. Molecular Imaging & Biology, 2016:1-9.

Yukiko H, Shuko T, Hansang C, et al. A Food and Drug Administration-approved asthma therapeutic agent impacts amyloid β in the brain in a transgenic model of Alzheimer disease.[J]. Journal of Biological Chemistry, 2015, 290(4):1966-1978.

Markova S V, Larionova M D, Burakova L P, et al. The smallest natural high-active luciferase: Cloning and characterization of novel 16.5-kDa luciferase from copepod Metridia longa[J]. Biochemical & Biophysical Research Communications, 2015, 457(1):77-82.

Abu‐Hayyeh S, Ovadia C, Lieu T M, et al. Prognostic and mechanistic potential of progesterone sulfates in intrahepatic cholestasis of pregnancy and pruritus gravidarum[J]. Hepatology, 2015.

Daniel W. Stuckey †, Shawn D. Hingtgen †, Karakas N, et al. Engineering Toxin-Resistant Therapeutic Stem Cells to Treat Brain Tumors[J]. Stem Cells, 2015, 33(2):589-600.

Duo X, Yang Z, Yanfeng Q, et al. Androgen Receptor Splice Variants Dimerize to Transactivate Target Genes.[J]. Cancer Research, 2015, 75(17):3663-71.

Zhang X, Ao Z, Bello A, et al. Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection.[J]. Antiviral Research, 2016, 127:20-31.

Piret J, Goyette N, Eckenroth B E, et al. Contrasting effects of W781V and W780V mutations in helix N of herpes simplex virus 1 and human cytomegalovirus DNA polymerases on antiviral drug susceptibility.[J]. Journal of Virology, 2015, 89(8):4636-4644.

A R Hacobian, K Posa-Markaryan, S Sperger, et al. Improved osteogenic vector for non-viral gene therapy[J]. European cells & materials, 2016, 31:191-204.

Savolainen M H, Xu Y, My?H?Nen T T, et al. Prolyl Oligopeptidase Enhances α-Synuclein Dimerization via Direct Protein-Protein Interaction.[J]. Journal of Biological Chemistry, 2015, 290(8):5117-26.

Leroy E, Defour J P, Sato T, et al. His499 Regulates Dimerization and Prevents Oncogenic Activation by Asparagine Mutations of the Human Thrombopoietin Receptor.[J]. Journal of Biological Chemistry, 2015, 20(2):268-279.

 

5. Coelenterazine 400a 腔腸素400a

【貨號(hào)】cat#340、CAS#70217-82-2

【簡介】可以被水母螢光素酶（Rluc)氧化，但不能被海腎螢光素酶氧化。它適用于實(shí)時(shí)檢測鈣離子、基因報(bào)告子實(shí)驗(yàn)以及BRET的首選底物。這種衍生物的最大激發(fā)波長約400nm，因此對對綠色熒光蛋白接收器的干擾最小。

【使用案例】

Namkung Y, Radresa O, Armando S, et al. Quantifying biased signaling in GPCRs using BRET-based biosensors[J]. Methods, 2015, 92:5-10.

6. GLuc GLOW Assay kit 海腎螢光素酶活性分析試劑盒

【貨號(hào)】cat#320

【簡介】它是一種新型的一步法GLOW分析試劑盒，適用于高通量篩選（HTS）。這種試劑盒包含一種能夠延長Gaussia信號(hào)超過幾個(gè)小時(shí)的緩沖液，Gaussia的半衰期在2-3小時(shí)之間。它的優(yōu)勢包括：一步法分析試劑（單一溶液包含裂解、稀釋和反應(yīng)緩沖液）、穩(wěn)定的發(fā)光信號(hào)（2-3小時(shí)的半衰期）、檢測分泌型Gaussia螢光素酶、檢測胞內(nèi)表達(dá)的Gaussia螢光素酶，以及低背景（高信號(hào)比）。

【使用案例】

Si C, Zhang Z, Wu Y, et al. Endoplasmic Reticulum Stress and Store-Operated Calcium Entry Contribute to Usnic Acid-Induced Toxicity in Hepatic Cells.[J]. Toxicological Sciences An Official Journal of the Society of Toxicology, 2015, 146(1).

 

7. Firefly Luciferin free acid 螢火蟲熒光素游離酸

【貨號(hào)】cat#306、CAS#2591-17-5

【簡介】純度99%，這是一種游離酸，而不是鉀鹽或者鈉鹽等水溶性鹽，需要使用堿性緩沖液溶解。

【使用案例】

Camille Saini †, Volodymyr Petrenko †, Pamela Pulimeno †, et al. A functional circadian clock is required for proper insulin secretion by human pancreatic islet cells[J]. Diabetes Obesity & Metabolism, 2015.

Tien-Jen L, Wen-Miin L, Pei-Wen H, et al. Rapamycin Promotes Mouse 4T1 Tumor Metastasis that Can Be Reversed by a Dendritic Cell-Based Vaccine.[J]. Plos One, 2015, 10(10).

Chang W T, Lai T H, Chyan Y J, et al. Specific Medicinal Plant Polysaccharides Effectively Enhance the Potency of a DC-Based Vaccine against Mouse Mammary Tumor Metastasis.[J]. Plos One, 2015, 10(3).

Lin T J, Lin H T, Chang W T, et al. Shikonin-enhanced cell immunogenicity of tumor vaccine is mediated by the differential effects of DAMP components[J]. Molecular Cancer, 2015, 14(1):1-13.

 

8. Coenzyme A 輔酶A

【貨號(hào)】cat#309、CAS#85-61-0、PubMed#6816

【簡介】腺苷-3-磷酸-5-二磷酸-泛酸酯（還原型），能夠延長螢火蟲螢光素酶生物發(fā)光信號(hào)。

【使用案例】

Paul Friedman K, Watt ED, Hornung MW, et al. Tiered High-Throughput Screening Approach to Identify Thyroperoxidase Inhibitors within the ToxCast Phase I and II Chemical Libraries.[J]. Toxicological Sciences, 2016.

 

9. Firefly Luc Assay Reagent 螢火蟲螢光素酶分析試劑

【貨號(hào)】cat#318

【簡介】一步法螢光素酶分析試劑盒，適用于檢測螢火蟲螢光素酶檢測，尤其是高通量篩選中的螢光素酶活性檢測。1000個(gè)反應(yīng)。具有最明亮的信號(hào)強(qiáng)度，最好的信號(hào)穩(wěn)定性。

【使用案例】

Sundeep M, Dolan T M, Maben Z J, et al. Adrenocorticotropic Hormone (ACTH) Responses Require Actions of the Melanocortin-2 Receptor Accessory Protein on the Extracellular Surface of the Plasma Membrane.[J]. Journal of Biological Chemistry, 2015, 290(46):27972-85.

Malik S, Dolan T M, Maben Z J, et al. ACTH Responses Require Actions of the Melanocortin-2 Receptor Accessory Protein on the Extracellular Surface of the Plasma Membrane.[J]. Journal of Biological Chemistry, 2015, 290(Suppl3):103-103(1).

 

10. Polyclonal Antisera-Gluc 螢光素酶多克隆抗血清

【貨號(hào)】cat#401P

【簡介】Gaussia螢光素酶的多克隆兔抗體，效價(jià)>1:10,000。

【使用案例】

Farideh M G, Church D R, Schreiber C L, et al. Inhibitor of p52 NF-κB subunit and androgen receptor (AR) interaction reduces growth of human prostate cancer cells by abrogating nuclear translocation of p52 and phosphorylated ARser81[J]. Genes & Cancer, 2015, 6(9-10):428-444.

 

11. Coelenterazine F 腔腸素F

【貨號(hào)】cat#345、CAS#123437-16-1

【簡介】腔腸素F是原水母發(fā)光蛋白的首選底物。

【使用案例】

Malikova N P, Borgdorff A J, Vysotski E S. Semisynthetic photoprotein reporters for tracking fast Ca(2+) transients.[J]. Photochemical & Photobiological Sciences, 2015, 14(12).

訂購鏈接：http:///tools/search.asp?kw2=%C7%BB%B3%A6%CB%D8&tn=5